Histologic features and MIB-1/Ki67 indices in atypical meningiomas (GII WHO)

被引:0
|
作者
Jozefowicz, Mateusz [1 ]
Papierz, Wielislaw [1 ]
机构
[1] Zaklad Patomorfol Katedry Patomorfol Uniw Medyczn, Ul Pomorska 251, PL-92213 Lodz, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2012年 / 12卷 / 02期
关键词
atypical meningiomas; benign meningiomas; histologic features; proliferative index;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical meningiomas are defined according WHO criteria as tumours characterized by: increased mitotic activity or three or more of the following histologic features: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, patternless or sheet like growth, and foci of "spontaneous" or "geographic" necrosis. It means, that those meningiomas which reveal only one or even two from above mentioned features are, according to WHO classification, still consistent with diagnosis of benign (GI WHO) tumours. Histologic slices from 65 atypical meningiomas were investigated and presence of each from those diagnostic histologic criteria which were mentioned above, were taken to account. Additionally, in the same way 59 benign meningiomas, which showed one or two histologic features characteristic for atypical type of the tumours, were analysed. In all cases immunohistochemical reaction with MIB-1 antibody was carried out and proliferating indices (PI) were established using image analysis computer system. Correlation between histologic criteria for atypical meningiomas and proliferating indices of the tumours was statistically estimated. We found a significant relationship between PI and mitotic activity, necrosis, small cells changes, patternless growth, nucleolies and number of histologic features that tumors present.
引用
收藏
页码:104 / 128
页数:25
相关论文
共 50 条
  • [31] MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors
    Abramovich, CM
    Prayson, RA
    HUMAN PATHOLOGY, 1998, 29 (12) : 1420 - 1427
  • [32] Ki67 (MIB1) in differential diagnosis between naevi and melanomas
    Vishnevskaya, Y.
    Martynkov, D.
    Savelov, N.
    EJC SUPPLEMENTS, 2007, 5 (04): : 400 - 400
  • [33] MIB-1(Ki-67) index and transforming growth factor-alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomas
    Hsu, DW
    Efird, JT
    Hedley-Whyte, ET
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1998, 24 (06) : 441 - 452
  • [34] Histopathologic features and MIB-1 labeling indices (L1) in recurrent versus non-recurrent meningiomas.
    Abramovich, CM
    Prayson, RA
    MODERN PATHOLOGY, 1998, 11 (01) : 158A - 158A
  • [35] Cavernous Malformations to Be Investigated for Familiarity: The Role of Ki67 MIB1
    Maiuri, Francesco
    Mariniello, Giuseppe
    Corvino, Sergio
    Somma, Teresa
    Guadagno, Elia
    Teodonno, Giuseppe
    De Caro, Marialaura Del Basso
    Cappabianca, Paolo
    WORLD NEUROSURGERY, 2021, 155 : E75 - E82
  • [36] The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma
    Ranjbari, Nastaran
    Rahim, Fakher
    MEDICAL HYPOTHESES, 2013, 80 (03) : 311 - 314
  • [37] The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas
    Johannessen, Anne Linn
    Torp, Sverre Helge
    PATHOLOGY & ONCOLOGY RESEARCH, 2006, 12 (03) : 143 - 147
  • [38] Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas
    Sachio Suzuki
    Hidehiro Oka
    Nobuyuki Kawano
    Satoshi Tanaka
    Satoshi Utsuki
    Kiyotaka Fujii
    Brain Tumor Pathology, 2002, 19 (1) : 47 - 47
  • [39] Usefulness of Ki-67 (MIB-1) immunostaining in the diagnosis of pulmonary sclerosing hemangiomas
    Kim, Baek-Hui
    Bae, Yoon-Sung
    Kim, Se Hoon
    Jeong, Hyeong-Jae
    Hong, Soon Won
    Yoon, Sun Och
    APMIS, 2013, 121 (02) : 105 - 110
  • [40] PROLIFERATION MARKERS MIB-1 (KI-67) AND PCNA IN PULMONARY NEUROENDOCRINE TUMORS
    DURHAM, JR
    NAKHLEH, RE
    SWANSON, PE
    FISCHER, JR
    ZARBO, RJ
    LABORATORY INVESTIGATION, 1994, 70 (01) : A150 - A150